21 November 2023
21 November 2023
MorphoSys intends to submit the investigational BET inhibitor for approval in the US and Europe in mid-2024.
The small molecule drug candidate BMX-001 has been previously granted orphan, fast track and breakthrough designations by the FDA.
Data wirelessly collected from the pill inside the stomach demonstrated it can accurately detect respiration and cardiac rate.
Wegovy has made headlines recently in the UK, highlighting both its seismic impact and changes in health habits.
The published data validated the AI-guided integrated genetic-epigenetic test PrecisionCHD for detecting coronary heart disease.
The multicentre and multinational study will assess the pharmacokinetics and safety of OMN6 in patients.
Eligible patients will take part in the 85-day trial with one optional follow-up assessment on day 120.
The study, with a target of enrolling at least 50 patients, is being carried out at eight clinical sites in the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
